businesswire

BariaTek Medical Receives € 1.5M DeepTech Non-dilutive Financing From Bpifrance BariTon™ Device to Enter Clinical Trials to Treat Obesity and Diabetes in the Near Future

Obesity and diabetes are high medical need pandemicsPARIS--(BUSINESS WIRE)--BariaTek Medical, a privately held medical device company dedicated to the development of minimally invasive endoscopically delivered solutions to treat obesity and diabetes, founded by Truffle Capital, announced it has secured a non-dilutive DeepTech financing of € 1.5 million from Bpifrance, under the “France 2030” plan, to accelerate the company's development towards its imminent human feasibility clinical trials. Obesity…